7:30AM - 8:15AM EDT Sheraton Times Square, Empire East
Genentech Breakfast Symposium: TECENTRIQ: First FDA-Approved Adjuvant Cancer Immunotherapy for Stage II to IIIA PD-L1+ NSCLC*
8:30AM - 10:30AM EDT Sheraton Times Square, Metropolitan East
Plenary Session: Lung Cancer Advances: New Treatment Paradigms in Operable NSCLC
David Jones, Memorial Sloan Kettering
Biography: David R. Jones, MD
Dr. Jones graduated Phi Beta Kappa from West Virginia University and received his medical degree from West Virginia University School of Medicine where he was AOA. He completed his Thoracic Surgery Residency at the University of North Carolina at Chapel Hill, NC. In 1999, Dr. Jones joined the faculty at the University of Virginia where he became Professor and Vice-Chairman of the Department. In 2013 Dr. Jones was recruited to Memorial Sloan Kettering Cancer Center as Chief of Thoracic Surgery.
Dr. Jones is Professor & Chief of Thoracic Surgery and Executive Vice-chair of the Department of Surgery at MSKCC. He is also the Co-Director of the Fiona and Stanly Druckenmiller Center for Lung Cancer Research. He is the current Secretary of the AATS and Chair of the AATS-MSKCC Thoracic Surgery Oncology Group (TSOG) for clinical trials. Dr. Jones is Associate Editor for the Journal of Thoracic and Cardiovascular Surgery. He is recent past Chair of the NIH/NCI Tumor Progression and Metastasis (TPM) study section and currently serves on the NCI Board of Scientific Advisors. He serves on numerous national and international committees related to thoracic surgical research and clinical care.
Dr. Jones’s research focuses on mechanisms and drivers of metastases in lung cancer. His research has been funded by the NIH/NCI, Department of Defense, and the AACR. He has been the Principal Investigator or Co-PI on over 35 funded grants and currently holds 2 R01 awards from the NCI. He has published over 380 papers and has written over 35 book chapters. He was an early adopter of VATS anatomic resections and minimally-invasive esophagectomies and performs the majority of his operations using these minimally-invasive approaches.
Jessica Donington, UChicago Medicine
Jessica S. Donington, MD, MSCR, is an expert thoracic surgeon who treats the full spectrum of lung, esophageal and mediastinal conditions. Her focus is on the comprehensive and multidisciplinary care of benign and malignant chest diseases.
Dr. Donington specializes in lung cancer and treats people at all stages, providing a personalized approach to diagnosis and treatment using the latest technology and innovations, including minimally invasive and robotic surgery.
In addition to her clinical practice, Dr. Donington is an avid researcher and respected leader in her field. Her research focus is in the discovery of novel biomarkers for early detection and treatment of lung cancer and clinical trials that incorporate surgery into multimodality care plans for locally advanced and metastatic lung cancer. Dr. Donington is a past president of Women in Thoracic Surgery and the New York Society for Thoracic Surgery and serves on the editorial boards for the Annals of Thoracic Surgery and the Journal of Thoracic Oncology.
10:00AM - 10:15AM EDT Sheraton Times Square
10:45AM - 12:00PM EDT Sheraton Times Square, Empire East
Concurrent Session B: Minimally-Invasive Pulmonary Segmentectomy
Robert Merritt, Wexner Medical Center
Robert E Merritt, MD is a Clinical Professor of Surgery and the Director of the Division of Thoracic Surgery at The Ohio State University Wexner Medical Center. Dr. Merritt graduated from Cornell University School of Medicine in 1998. He completed his general surgery residency at the New York Hospital-Cornell Medical Center in 2005. He completed his cardiothoracic surgery residency at the Massachusetts General Hospital in 2007. He served as an assistant professor in cardiothoracic surgery at the Stanford Hospitals and Clinics from September 2008 to January 2014. He joined Division of Thoracic surgery at The Ohio State University Wexner Medical Center in January 2014. His clinical interests include robotic surgery for lung cancer and minimally invasive esophagectomy for esophageal cancer. His research interests include outcomes research, racial disparities in surgical care, and identifying unique biomarkers for lung cancer.
Paula Ugalde Figueroa, Brigham and Women's Hospital
Dr. Paula Ugalde Figueroa established herself as a thoracic surgeon dedicated to research. She has an extensive record of publications including an impressive body of work on thoracic surgery using innovative uniportal VATS approaches for lung cancer.
Dr. Ugalde serves on the IASLC Board of Directors since 2021, as well as being a member of the American Association of Thoracic Surgery (AATS), Society of Thoracic Surgeons (STS). Additionally, Dr. Ugalde is the acting Chair of International Affairs for the Women in Thoracic Surgery society.
In the fall of 2021 Dr. Ugalde joined the Division of Thoracic and Cardiac Surgery at Brigham and Women’s Hospital in Boston, MA as an Associate Thoracic Surgeon. She is also a Member of the Faculty at Harvard Medical School, as well as a part-time staff member of the Dana-Farber Cancer Institute.
10:45AM - 12:00PM EDT Sheraton Times Square, Metropolitan East
Concurrent Session A: Multidisciplinary Therapeutic Strategies in Operable Esophageal Cancer
Daniela Molena, Memorial Sloan Kettering Cancer Center
Dr. Daniela Molena is an Associate Professor of Surgery at Weill Cornell Medicine and Associate Attending and Director of the Esophageal Program at Memorial Sloan Kettering Cancer Center (MSKCC). She is the Chair of the Thoracic Education Committee with the AATS, a Member of the AATS Thoracic Quality Committee and a Member of the Board of Directors of the AATS Foundation. She is also the Vice President of the Women in Thoracic Surgery and a Councilor of the Southern Thoracic Surgical Association. Dr Molena is a Deputy Editor for the Annals of Thoracic Surgery and associate Editors for Disease of the Esophagus. She serves in numerous national and international committees related to esophageal and thoracic surgery.
Thomas D'Amico, Duke University
Dr. Thomas A. D’Amico is a graduate of Harvard University (BA) and the College of Physicians & Surgeons of Columbia University (MD). He received training in General Surgery and Thoracic Surgery at Duke University Medical Center. After completing a Fellowship in Thoracic Surgical Oncology at the Memorial Sloan-Kettering Cancer Center, Dr. D’Amico joined the faculty at Duke University Medical Center in 1996. He is currently the Gary Hock Endowed Professor, Chief of General Thoracic Surgery, and Director of the Thoracic Oncology Program of the Duke Cancer Institute
Dr. D’Amico is in leadership positions in the American Association for Thoracic Surgery, including the Board of Directors, the Membership Committee, and the Ethics Committee. He is an Associate Editor for the Journal of Thoracic and Cardiovascular Surgery and serves on the editorial board of the Annals of Surgery and the Journal of the American College of Surgeons. Finally, he is the active in the NCCN, as a member of NCCN Board of Directors and Guidelines Steering Committee, the Chair of the Quality and Outcomes Committee, as well as a member of the Non-Small Cell Lung Cancer and Small Cell Lung Cancer Guidelines Committees and co-chair of the Esophageal Cancer Guidelines Committee.
11:30AM - 12:00PM EDT Sheraton Times Square
Break | Visit Exhibit Hall
12:30PM - 1:15PM EDT Sheraton Times Square, Metropolitan East
Lunch Symposium: Precision Decisions in Multimodal Management of Early-Stage NSCLC: Integrating EGFR-Targeted Therapy in Perioperative Settings. This activity is supported by an independent educational grant from AZ. (CME Provided by PVI)
12:30PM - 1:15PM EDT Sheraton Times Square, Empire East
Intuitive Lunch Symposium: Building a Robotic Thoracic Oncology Program*
12:45PM - 1:15PM EDT Sheraton Times Square
Break | Visit Exhibit Hall
1:45PM - 3:15PM EDT Sheraton Times Square, Empire East
Concurrent Session D: Mediastinal Tumors*
Shaf Keshavjee, Toronto General Hospital, University Health Network
Dr. Shaf Keshavjee completed his medical training at the University of Toronto in 1985, and subsequently trained in General Surgery, Cardiac Surgery and Thoracic Surgery at the University of Toronto followed by fellowship training at Harvard University and the University of London for airway surgery and heart-lung transplantation, respectively. He leads a team whose studies in transplantation have had a significant impact on treatment outcomes for patients with lung disease around the world. Dr. Keshavjee is currently Chief of Innovation at University Health Network, University of Toronto.
An integral part of the Division of Thoracic Surgery at UHN, Dr. Keshavjee has taken on leadership roles in all facets of this specialized area of care: as a skilled surgeon and Director of the Toronto Lung Transplant Program; and as a researcher and Director of the Latner Thoracic Research Laboratories. To improve lung function after transplantation, he developed a lung preservation solution to preserve donor lungs for transplant. This solution has become the standard technique used by transplantation programs around the world. Dr.Keshavjee has further attracted worldwide attention for his pioneering research to recondition and repair injured human donor lungs using gene and cell therapies and the Toronto Ex Vivo Lung Perfusion System, making them suitable for transplantation into patients and enhancing the number of donor lungs available.
Dr. Keshavjee has served on the Board of Directors of the ISHLT and the Canadian Society of Transplantation. He has served as a Member of the Board, Treasurer and then the 102nd President of the AATS. He has received numerous awards and honorary fellowships for his continuing contributions to his field, including several lifetime achievement awards. Dr. Keshavjee has recieved several honorary doctoral degrees, the Order of Ontario, and Canada's highest civilian honor as Officer of the Order of Canada for his contributions to medicine.
Hiroshi Date, Kyoto University Hospital
Hiroshi Date, MD is a Chairman and Professor, Department of Thoracic Surgery, Kyoto University, Japan. After graduating from Okayama University School of Medicine in 1984, he was trained by Drs Joel D Cooper and G Alexander Patterson at Washington University as a research (1989-91) and a clinical lung transplant fellow (1994-5). He also spent a year (1993-4) as a general thoracic fellow at The Cleveland Clinic Foundation. In 1998, he performed the first successful living-donor lobar lung transplantation in Japan. Since then, he has performed more than 300 lung transplants resulting in about 70% survival rate at 10-years. Dr. Date has performed more than 4,000 thoracotomies and has authored more than 600 peer-reviewed publications in various fields of general thoracic surgery including thoracic malignancy and lung transplantation.
1:45PM - 3:15PM EDT Sheraton Times Square, Metropolitan East
Concurrent Session C: Technical Aspects of Pulmonary Segmentectomy
Christopher Seder, Rush University Medical Center
Dr. Seder is the Arthur E. Diggs, MD and L. Penfield Faber, MD Chair of Surgical Sciences and Chief of Thoracic Surgey at Rush University Medical Center. His academic interests include investigating blood-based tumor markers to identify lung cancers at the earliest stage, outcomes research, and resident education. Dr. Seder is also the cardiothoracic surgery residency program director and has been awarded the L. Penfield Faber Teaching Award for excellence in education multiple times.
Anthony Kim, Keck Hospital of USC
Anthony W. Kim M.D., M.S. is the Chief of Division of Thoracic Surgery and Professor of Clinical Surgery in the Department of Surgery at the Keck School of Medicine and the Vice Chair, Clinical Operations for the Department of Surgery at the University of Southern California in Los Angeles, California. He is also the Co-Director of the Thoracic Oncology Program at the Keck and Norris Hospitals of the University of Southern California.
2:45PM - 3:00PM EDT Sheraton Times Square
3:30PM - 5:00PM EDT Sheraton Times Square, Empire East
Concurrent Session F: Diagnosis and Staging in NSCLC
Chadrick Denlinger, Indiana University
Dr. Denlinger is a tenured Professor of Surgery at Indiana University who joined the faculty there in 2020. He is a graduate of the Ohio State University College of Medicine and completed his general surgery and thoracic training at the University of Virginia and Washington University. His clinical interests include the treatment of lung and esophageal cancers, benign foregut surgery and lung transplantation. He currently serves as an editorial board member for the Journal of Thoracic and Cardiovascular Surgery as well as the Annals of Thoracic Surgery.
Benjamin Kozower, Barnes-Jewish Hospital
Professor of Surgery
Vice-Chair, Patient Safety and Quality Improvement
3:30PM - 4:45PM EDT Sheraton Times Square, Metropolitan East
Concurrent Session E: Lung Cancer Screening and Management of the Incidental GGO and Semi-Solid Nodule
Betty Tong, Duke University Medical Center
Betty C. Tong, MD, MHS is an Associate Professor of Surgery at the Duke University Medical Center in Durham, North Carolina, USA. Her clinical interests are in lung cancer screening, surgical management of thoracic malignancies such as lung cancer and soft tissue sarcoma of the chest, and video assisted thoracic surgery. Her research interests are centered in the area of health services research, and include the study of disparities in thoracic surgical patients, and patient preferences and decision making in the management of thoracic disease.
Dao Nguyen, UHealth System
Doctor Nguyen obtained his medical degree at McGill University, Montreal QC Canada in 1986 (MDCM) He completed general surgery and cardiothoracic surgery residencies at the same institution in 1992 and 1994 respectively. He completed a research/clinical super fellowship in thoracic oncology at MD Anderson (1996). He is board-certified in Thoracic Surgery by the Royal College of Surgeons of Canada and b the American Board of Thoracic Surgery. After a short stay at McGill University (1996-1998) as a junior faculty member of the division of CT surgery, Dr Nguyen was recruited to join Dr David Schrump of the Section of Thoracic Surgery, Surgery Branch (NCI/NIH) where he remained for 9 years as senior investigator (1998-2007). He resumed the position of chief of thoracic surgery at the University of Miami (2007) until the present time. He currently holds the B. and Donald Carlin Endowed Chair of Thoracic Surgical Oncology. The focus of Dr Nguyen clinical research is the implementation of Enhanced Recovery after Surgery for thoracic patients and quality improvement process to achieve minimal postoperative pain and opioid utilization after thoracic surgical procedures. His clinical interest is minimally invasive thoracic surgery particularly robotic thoracic operations as well as clinical outcomes of patients undergoing pulmonary resection for primary lung cancer especially in the “enhanced recovery” era and following “textbook oncology practice leading to textbook oncology outcomes”.
4:30PM - 6:00PM EDT Sheraton Times Square
Welcome Reception in the Exhibit Hall
5:00PM - 6:30PM EDT Sheraton Times Square
Case Video Competition
5:00PM - 6:30PM EDT Sheraton Times Square
Bryan Burt, Baylor College of Medicine
Dr. Burt is Professor and Chief of the Division of Thoracic Surgery at Baylor College of Medicine. He is Feature Editor for the Journal of Thoracic and Cardiovascular Surgery. Dr. Burt is a surgeon-scientist with an NIH-funded laboratory and an active research program in thoracic oncology. Dr. Burt is also a clinical trialist who leads several investigator-initiated clinical trials in immuno-oncology.
Bernard Park, Memorial Sloan Kettering Cancer Center
Bernie Park is a general thoracic surgeon that specializes in thoracic surgical oncology. He is Deputy Chief of Clinical Affairs of the Thoracic Service at Memorial Sloan-Kettering Cancer Center. He has a particular interest in advanced minimally invasive techniques and has developed and studied robotic approaches for treatment of thoracic malignancy since 2002.
6:45PM - 7:30PM EDT Sheraton Times Square, Metropolitan East
Dinner Symposium: Setting Our Sights on Cure in Resectable NSCLC: Getting the Details of Perioperative Immunotherapy Right. This activity is supported by educational grants from AZ, BMS, Genentech, and Merck. (CME Provided by PVI)
No added events available on this day